View in EDS HTML Full Text PDF Full Text

Target-Enhanced Whole-Genome Sequencing Shows Clinical Validity Equivalent to Commercially Available Targeted Oncology Panel.

Saved in:
Bibliographic Details
Title: Target-Enhanced Whole-Genome Sequencing Shows Clinical Validity Equivalent to Commercially Available Targeted Oncology Panel.
Authors: Lee, Sangmoon1 (AUTHOR), Roh, Jin2 (AUTHOR), Park, Jun Sung3 (AUTHOR), Tuncay, Islam Oguz1 (AUTHOR), Lee, Wonchul1 (AUTHOR), Kim, Jung-Ah1 (AUTHOR), Oh, Brian Baek-Lok1 (AUTHOR), Shin, Jong-Yeon1 (AUTHOR), Lee, Jeong Seok1 (AUTHOR), Ju, Young Seok1 (AUTHOR), Kim, Ryul1 (AUTHOR), Park, Seongyeol1 (AUTHOR), Koo, Jaemo1 (AUTHOR), Park, Hansol1 (AUTHOR), Lim, Joonoh1 (AUTHOR), Connolly-Strong, Erin1 (AUTHOR), Kim, Tae-Hwan4 (AUTHOR), Choi, Yong Won4 (AUTHOR), Ahn, Mi Sun4 (AUTHOR), Lee, Hyun Woo4 (AUTHOR)
Source: Cancer Research & Treatment. Apr2025, Vol. 57 Issue 2, p350-361. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15982998
DOI:10.4143/crt.2024.114